The use of
injectable Calcium Hydroxylapatite (CaHA) has expanded beyond traditional
dermal filling to embrace regenerative medicine principles in aesthetics.
Radiesse®, a CaHA-based injectable, serves dual roles as a volumizer and
biostimulant, promoting neocollagenesis and neoelastogenesis. This article
reviews current clinical applications, mechanisms of action, and supporting
evidence for Radiesse® as a regenerative tool for facial and body rejuvenation.
Introduction
Regenerative
aesthetics focuses on restoring tissue health, structure, and function by
stimulating the body’s natural regenerative processes. Among injectable
biostimulatory agents, Calcium Hydroxylapatite (CaHA) has gained attention for
its ability to volumize and promote dermal remodeling.
Radiesse®,
a CaHA-based injectable, has demonstrated clinical efficacy in improving skin
quality, firmness, and contour, with applications extending beyond the face to
areas such as the neck, décolletage, arms, thighs, and buttocks.
Mechanism
of Action
Radiesse®
consists of 30% synthetic CaHA microspheres (25–45 microns) suspended in a 70%
aqueous carboxymethylcellulose (CMC) gel carrier.
Upon injection:
- The CMC gel provides immediate
volumization.
- CaHA particles create a
scaffold that stimulates fibroblasts.
- Over time, the gel is resorbed
while CaHA promotes neocollagenesis, neoelastogenesis, and
angiogenesis, contributing to dermal thickening and improved skin quality.
Histological
studies confirm type I and III collagen formation and elastin fiber
regeneration around CaHA microspheres over several months, with aesthetic
benefits persisting beyond 12 months.
Clinical
Applications
Radiesse®
is FDA-approved for moderate to severe facial wrinkles and folds (e.g.,
nasolabial folds) and correction of volume loss in the dorsum of the hands.
Its regenerative applications include:
- Facial rejuvenation: Midface, jawline, and temple
contouring.
- Neck and décolletage: Improving skin laxity,
texture, and fine lines.
- Body contouring: Buttock lifting, upper arm
skin tightening, and thigh firming.
- Scar management: Enhancing dermal matrix
quality in areas of atrophy or trauma.
Recent
evidence supports its utility in hyperdiluted form for skin quality improvement
without significant volumization — especially in thin-skinned or lax areas.
Evidence
from Clinical Studies
The
narrative review consolidated findings from numerous clinical trials and
histological analyses:
- Long-lasting volumization with
sustained improvements in skin firmness and elasticity.
- High patient satisfaction rates
for both aesthetic outcome and natural appearance.
- Significant increases in dermal
thickness and collagen density demonstrated via ultrasound and
histopathology.
- Minimal adverse events,
predominantly limited to expected injection-site effects such as swelling
and bruising.
Safety
Profile
Radiesse®
exhibits a strong safety record with a low incidence of complications when
administered by trained injectors. Reported side effects are typically
transient and self-limiting. Proper technique, product dilution, and patient
selection are critical to minimizing risks, particularly in thin-skinned or
vascular areas.
Conclusion
Calcium
Hydroxylapatite (Radiesse®) has evolved into a cornerstone of regenerative
aesthetic practice, offering both immediate volumetric enhancement and
long-term dermal regeneration. Its versatility across facial and body
indications, combined with its biostimulatory properties, positions it as an
essential tool for practitioners seeking natural, tissue-restorative outcomes
in aesthetic medicine.
Reference
Fabi SG,
et al. The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative
Aesthetic Treatment: A Narrative Review. Aesthetic Surgery Journal.
2023;43(10):1063–1078. Available
here